Notice2024-26000
Advisory Committee on Immunization Practices; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 8, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces an amendment to the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting was open to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 217 (Friday, November 8, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 217 (Friday, November 8, 2024)]
[Notices]
[Page 88780]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-26000]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2024-0072]
Advisory Committee on Immunization Practices; Amended Notice of
Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces an amendment
to the following meeting of the Advisory Committee on Immunization
Practices (ACIP). This meeting was open to the public.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management
Specialist, Advisory Committee on Immunization Practices, National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-8836; Email: <a href="/cdn-cgi/l/email-protection#5514161c05153631367b323a23"><span class="__cf_email__" data-cfemail="1b5a58524b5b787f78357c746d">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Advisory Committee on Immunization Practices (ACIP);
October 23, 2024, from 8 a.m. to 5:30 p.m., EDT, and October 24, 2024,
from 8 a.m. to 5:30 p.m., EDT (times subject to change; see the ACIP
website for updates: <a href="https://www.cdc.gov/vaccines/acip/index.html">https://www.cdc.gov/vaccines/acip/index.html</a>), in
the original Federal Register notice.
Notice of the virtual meeting was published in the Federal Register
on September 30, 2024, 89 FR 79610-79611.
The meeting notice is being amended to update the recommendation
votes in the matters to be considered, which should read as follows:
Matters to be Considered: The agenda will include discussions on
chikungunya vaccines, COVID-19 vaccines, cytomegalovirus (CMV) vaccine,
Human papillomavirus (HPV) vaccines, influenza vaccines, meningococcal
vaccines, mpox vaccines, pneumococcal vaccines, Respiratory Syncytial
Virus (RSV) vaccines for adults, RSV vaccines for maternal and
pediatric populations, and the adult and child/adolescent immunization
schedules. Recommendation votes are scheduled for COVID-19 vaccines,
meningococcal vaccines, pneumococcal vaccines, and the adult and child/
adolescent immunization schedules. A Vaccines for Children (VFC) vote
is scheduled for influenza vaccines and meningococcal vaccines. For
more information on the meeting agenda, visit <a href="https://www.cdc.gov/acip/meetings/index.html">https://www.cdc.gov/acip/meetings/index.html</a>.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-26000 Filed 11-7-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 8, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.